Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. (Q35975748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

S C Fraser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

H J Dobbs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

S R Ebbs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

L J Fallowfield

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

M Baum

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

language of work or name

English

0 references

publication date

1 February 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

402-406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

Measuring health status: a new tool for clinicians and epidemiologists

12 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Does chemotherapy improve survival in advanced breast cancer? A statistical overview

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

The design of advanced breast cancer trials. New approaches

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Evaluation of quality of life in patients receiving treatment for advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Cancer chemotherapy and quality of life

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968186

Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer

24 September 2018

1 reference

12 December 2020

A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast

1 reference

12 December 2020

Quality of life of cancer patients at different stages in the disease trajectory

1 reference

12 December 2020

Advanced breast cancer. A randomised trial of epidoxorubicin at two different dosages and two administration systems

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431375%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

PubMed publication ID

8431375

1 reference